SEC Filings

Pharmaxis delisted from the Nasdaq Global Market on 23 July 2009, having initially listed our American Depositary Receipts (ADRs) in August 2005. Our filing obligations with the SEC were suspended on 3 August 2009.

Our ADRs are now traded in the U.S. on the over the counter market - a Level 1 ADR Program. Our reporting obligations under this program are met by the information we post to the News and Investor sections of this website.

Our historical SEC filings are listed below.

For further information, visit our ASX Announcements section and our News centre.

Note that in 2008 we provided an integrated Statutory Annual Report that combined our Australian and US reporting requirements and disclosures in one comprehensive document.


16 September 2008	2008 Annual Report on Form 20-F
27 November 2007	2007 Annual Report on Form 20F
11 October 2007	NASDAQ media release: Placement and SPP
05 June 2007	Form 20F/A-1: Amendment 1 to Form 20-F
22 February 2007	F3, Shelf Registration. Feb 2007
06 December 2006	2006 Annual Report on Form 20F
26 August 2005	Registration Statement on Form 20F
26 August 2005	Registration Statement on Form 20F - exhibits
26 September 2005	Registration Statement on Form F1
18 October 2005	Form F1 Amendment No.1
09 November 2005	US Prospectus
21 December 2005	2005 Annual Report on Form 20F

SEC Filings

RECENT SEC FILINGS